European Alpha-1 Research Collaboration (EARCO) em Portugal: O Futuro Está a Acontecer

Autores

  • Maria Sucena Pulmonology Department. Hospital de Santo António. Unidade Local de Saúde de Santo António. Porto.
  • Raquel Marçôa Pulmonology Department. Hospital Eduardo Santos Silva. Unidade Local de Saúde Gaia e Espinho. Vila Nova de Gaia.
  • Catarina Guimarães Pulmonology Department. Hospital da Senhora da Oliveira. Unidade Local de Saúde Alto Ave. Guimarães.

DOI:

https://doi.org/10.20344/amp.20953

Palavras-chave:

Deficiência de alfa 1-Antitripsina, Portugal, Sistema de Registos

Resumo

N/A.

Downloads

Não há dados estatísticos.

Referências

Cortes-Lopez R, Barjaktarevic I. Alpha-1 antitrypsin deficiency: a rare disease? Curr Allergy Asthma Rep. 2020;20:51.

Blanco IB, Diego I, Pérez -hS, Lara B, Maldonado F, Esquinas C, et al. Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide. Int J Chron Obstruct Pulmon Dis. 2017;12:1683-94.

Meira L, Boaventura R, Seixas S, Sucena M. Alpha-1 antitrypsin deficiency detection in a Portuguese population. COPD. 2018;15:4-9.

Spínola C, Bruges-Armas J, Pereira C, Brehm A, Spínola H. Alpha-1-antitrypsin deficiency in Madeira (Portugal): the highest prevalence in the world. Respir Med. 2009;103:1498-502.

Miravitlles M, Chorostowska-Wynimko J, Ferrarotti I, McElvaney NG, O’Hara K, Stolk J, et al. The European Alpha-1 Research Collaboration (EARCO): a new ERS clinical research collaboration to promote research in alpha-1 antitrypsin deficiency. Eur Respir J. 2019;53:1900138.

Greulich T, Altraja A, Barrecheguren M, Bals R, Chlumsky J, Chorostowska-Wynimko J, et al. Protocol for the EARCO registry: a pan-European observational study in patients with α1-antitrypsin deficiency. ERJ Open Res. 2020;6:00181-2019.

Miravitlles M, Turner AM, Torres-Duran M, Tanash H, Rodríguez-García C, López-Campos JL, et al. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry. Respir Res. 2022;23:352.

Lopes AP, Mineiro MA, Costa F, Gomes J, Santos C, Antunes C, et al. Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology. 2018;24:s1-21.

Sucena M, Gomes J, Guimarães C, Miravitlles M. Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now. Pulmonology. 2020;26:181-3.

Barrecheguren M, O’Hara K, Wilkens M, Boyd J, Kolda E, Lara B, et al. Research priorities in α1- antitrypsin deficiency: results of a patients’ and healthcare providers’ international survey from the EARCO Clinical Research Collaboration. ERJ Open Res 2020;6:00523-2020.

Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, et al. Opinions and attitudes of pulmonologists about augmentation therapy in patients with alpha-1 antitrypsin deficiency. a survey of the EARCO group. Int J Chron Obstruct Pulmon Dis. 2022;17:53-64.

Downloads

Publicado

2024-11-04

Como Citar

1.
Sucena M, Marçôa R, Guimarães C. European Alpha-1 Research Collaboration (EARCO) em Portugal: O Futuro Está a Acontecer. Acta Med Port [Internet]. 4 de Novembro de 2024 [citado 5 de Novembro de 2024];37(11):754-6. Disponível em: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/20953

Edição

Secção

Perspectiva